DE RONCHI, DIANA
 Distribuzione geografica
Continente #
NA - Nord America 13.372
AS - Asia 11.074
EU - Europa 9.415
AF - Africa 849
SA - Sud America 732
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 7
Totale 35.503
Nazione #
US - Stati Uniti d'America 13.182
SG - Singapore 2.965
IT - Italia 2.938
CN - Cina 2.859
VN - Vietnam 2.380
GB - Regno Unito 1.809
DE - Germania 1.099
HK - Hong Kong 990
SE - Svezia 821
FR - Francia 675
BR - Brasile 535
IN - India 511
RU - Federazione Russa 445
UA - Ucraina 443
BD - Bangladesh 333
SC - Seychelles 285
IE - Irlanda 277
NL - Olanda 250
KR - Corea 234
CI - Costa d'Avorio 197
JP - Giappone 187
ZA - Sudafrica 173
JO - Giordania 147
EE - Estonia 126
FI - Finlandia 109
TG - Togo 104
CA - Canada 87
BG - Bulgaria 76
AR - Argentina 74
MX - Messico 71
PH - Filippine 60
ID - Indonesia 57
CH - Svizzera 54
AT - Austria 51
PK - Pakistan 48
ES - Italia 47
AU - Australia 45
TR - Turchia 44
IQ - Iraq 43
PL - Polonia 39
BE - Belgio 36
EC - Ecuador 35
TH - Thailandia 35
CL - Cile 25
CO - Colombia 23
SA - Arabia Saudita 23
GR - Grecia 22
UZ - Uzbekistan 20
MY - Malesia 18
TW - Taiwan 16
IL - Israele 15
LT - Lituania 15
LB - Libano 13
MA - Marocco 13
NO - Norvegia 13
PY - Paraguay 13
KE - Kenya 12
NP - Nepal 12
DK - Danimarca 10
EG - Egitto 10
PE - Perù 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
JM - Giamaica 9
KZ - Kazakistan 9
TN - Tunisia 9
DZ - Algeria 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
RO - Romania 8
CZ - Repubblica Ceca 6
HU - Ungheria 6
IR - Iran 6
PT - Portogallo 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
SI - Slovenia 5
SN - Senegal 5
CR - Costa Rica 4
GE - Georgia 4
KW - Kuwait 4
MK - Macedonia 4
OM - Oman 4
UY - Uruguay 4
AL - Albania 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
RS - Serbia 3
SY - Repubblica araba siriana 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 35.453
Città #
Singapore 1.927
Southend 1.488
Fairfield 1.348
Ashburn 1.252
Hong Kong 919
Cambridge 916
Santa Clara 831
San Jose 768
Woodbridge 623
Seattle 609
Chandler 607
Wilmington 577
Hefei 557
Houston 551
Ho Chi Minh City 518
Bologna 496
Hanoi 456
Ann Arbor 450
Dong Ket 402
Princeton 400
Beijing 375
Boardman 293
Jacksonville 289
Dublin 273
Lauterbourg 233
Seoul 219
Abidjan 197
Milan 195
Los Angeles 192
Rome 191
Nanjing 175
Dallas 163
Westminster 163
Tokyo 161
Padova 154
New York 149
Amman 147
Council Bluffs 146
Buffalo 124
Berlin 114
Lomé 104
Saint Petersburg 99
Turin 90
The Dalles 89
Jinan 84
Helsinki 80
San Diego 79
Redondo Beach 76
Sofia 73
Shenyang 71
Guangzhou 70
Mülheim 70
Haiphong 62
Frankfurt am Main 61
Changsha 60
São Paulo 59
Florence 58
Shanghai 58
Da Nang 57
Bengaluru 56
London 55
Des Moines 54
Nanchang 53
Tianjin 52
Chicago 51
Naples 51
Hebei 45
Mexico City 45
Modena 36
Orem 36
Atlanta 35
Phoenix 35
Jiaxing 34
Brussels 33
Bari 32
Burlington 32
Grafing 32
Nuremberg 32
Verona 32
Mahé 31
Zhengzhou 31
Dearborn 30
Genoa 29
Montreal 29
Ningbo 28
Jakarta 27
Redwood City 27
Hangzhou 26
Munich 26
Paris 26
San Francisco 26
Amsterdam 25
Bern 25
Moscow 25
Thái Nguyên 24
Parma 23
Warsaw 23
Brescia 22
Falkenstein 22
Falls Church 22
Totale 22.426
Nome #
Il suicidio assistito per pazienti con depressione grave. Un’opzione inaccettabile che gli psichiatri devono combattere fermamente 1.008
A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia 270
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 262
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 258
Pet therapy in elderly patients with mental illness. 244
Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs 239
Occurrence of cognitive impairment after age 90: usefulness and drawbacks of four broadly used concepts. 234
DISABILITÀ INTELLETTIVE: DAL CONCETTO DI DEFICIT A QUELLO DI FUNZIONAMENTO ADATTIVO 230
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 228
Eating disorders in narcolepsy type 1: Evidence from a cross-sectional Italian study 226
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 226
Animal-assisted interventions for elderly patients affected by dementia or psychiatric disorders: a review. 226
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 224
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 223
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 218
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 218
The 5-HT2C receptor as a target for mood disorders. 217
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 216
Anxiety symptoms in 74+ community-dwelling elderly: associations with physical morbidity, depression and alcohol consumption 212
Le demenze 209
COMT and age at onset in mood disorders: a replication and extension study. 209
Predictive coding in neuropsychiatric disorders: A systematic transdiagnostic review 204
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 202
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 200
Cognitive Impairment after Age 60: Clinical and Social Correlates in the "Faenza Project" 198
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 197
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons 196
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 195
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 194
Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. 194
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 194
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies 193
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 190
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients 189
Vortioxetine treatment-emergent mania in the elderly: a case report 189
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 188
Never too late to be anxious: validation of the Geriatric Anxiety Inventory, Italian version 186
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 184
Suicide attempts in eating disorder subtypes: A meta-analysis of the literature employing DSM-IV, DSM-5, or ICD-10 diagnostic criteria 184
Compulsory treatments in eating disorders: a systematic review and meta-analysis 184
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 183
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 182
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 182
Assessing motivation for treatment in eating disorders: psychometric validation of the Italian version of the Autonomous and Controlled Motivation for Treatment Questionnaire (ACMTQ-ITA) 181
Sleep disturbances in individuals with first episode psychosis and clinical high-risk states: A systematic review 181
Sex-specific issues in eating disorders: a clinical and psychopathological investigation 180
Still waiting: referral patterns, delays, and key factors in accessing specialized eating disorder treatment in an Italian cohort 179
Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder? 179
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 179
TAAR 6 and HSP-70 variations associated with bipolar disorder 179
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 179
Prevalence and Gender Differences in Late-Life Depression: A Population-Based Study. 179
Lack of Association between Interleukin-1 alpha rs1800587 Polymorphism and Alzheimer's Disease in Two Independent European Samples 179
TAAR6 variations possibly associated with antidepressant response and suicidal behavior 178
Alexithymia: phisiopathology, etiology and management 178
Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis 177
Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project. 175
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 174
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. 174
Depressive symptomatology is influenced by chronotypes 173
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 172
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project 171
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. 171
Vision and hearing impairments are associated with depressive--anxiety syndrome in Italian elderly. 170
Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects? 170
Personality and Genetics 169
Late-Life Mental Health Disorders. Data from a Population-Based Study 169
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 168
Schizofrenia: genetica, prevenzione e riabilitazione 168
Thyroid hormones affect recovery from depression during antidepressant treatment 167
Beyond anorexia and bulimia nervosa: what's "new" in eating disorders? 166
The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia 165
Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases 164
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. 164
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 164
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol 163
Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease 163
Epigenetic basis of psychiatric disorders: a narrative review 162
Influence of TAAR6 polymorphisms on response to aripiprazole 161
The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients 161
Temperament and character of suicide attempters 160
Schizophrenia: genetics, prevention and rehabilitation 160
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients 160
The missing link between philosophy and psychopathology 160
Suicide risk in Obsessive-Compulsive Disorder and exploration of risk factors: a systematic review 160
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 159
Different classification systems yield different dementia occurrence among nonagenarians and centenarians. 159
Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder 158
Antidepressant response in the elderly. 158
Psychopathology of first-episode psychosis in HIV-positive persons in comparison to first-episode schizophrenia: a neglected issue. 158
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy. 157
Dysbindin gene (DTNBP1) and schizophrenia in Korean population 156
Tyrosine Hydroxylase and DOPA Decarboxylase Gene Variants in Personality Traits 155
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder 155
Eating Disorders and Disturbed Eating Behaviors Underlying Body Weight Differences in Patients Affected by Endometriosis: Preliminary Results from an Italian Cross-Sectional Study 154
The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. 153
Estrogen receptor gene 1 variants are not associated with suicidal behavior 153
TPH2 gene variants and anxiety during alcohol detoxification outcome 152
The combined effect of age, education, and stroke on dementia and cognitive impairment no dementia in the elderly. 151
Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting. 151
Totale 19.286
Categoria #
all - tutte 95.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021664 0 0 0 0 0 0 0 0 0 0 0 664
2021/20223.274 324 97 230 288 281 178 69 275 112 364 586 470
2022/20233.262 332 446 149 370 244 203 119 203 645 96 288 167
2023/20241.160 75 164 68 128 88 217 100 90 40 81 40 69
2024/20255.345 150 646 345 287 1.096 284 258 167 137 402 331 1.242
2025/202613.765 885 1.446 1.175 1.137 1.389 665 1.382 1.128 2.220 978 809 551
Totale 35.989